- Report
- October 2024
- 190 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- April 2025
- 576 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- July 2024
- 96 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2024
- 117 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2023
- 116 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 94 Pages
Global
From €3500EUR$4,119USD£3,077GBP
The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are typically performed in a laboratory setting and can provide valuable information to healthcare providers.
The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less Read more